🇺🇸 FDA
Patent

US 7211255

Contraceptives based on SP22 and SP22 antibodies

granted A61KA61K2039/54A61K35/52

Quick answer

US patent 7211255 (Contraceptives based on SP22 and SP22 antibodies) held by United States of America The U.S. Environmental Protection Agency expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America The U.S. Environmental Protection Agency
Grant date
Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/54, A61K35/52, A61K38/00, A61K39/00